2006 Biosimilars Packaging Therapies 
The Pharma Data
APRIL 4, 2023
Biosimilars help patients to gain broader access to effective and high-quality treatments that improve their disease therapies,” said Rebecca Guntern, Head of Region Europe, Sandoz. It has a leading global portfolio with eight marketed biosimilars and a further 15+ in various stages of development.
Agency IQ
AUGUST 2, 2024
September 30, 2024 PDUFA Novel Approaches to Development of Cell and Gene Therapy Convene a public meeting to solicit input on methods and approaches (e.g., use of RWE, registries) for capturing post-approval safety and efficacy data for cell and gene therapy products.
Agency IQ
JULY 28, 2023
A big legislative question about PAHPA Reauthorization : The Pandemic and All-Hazards Preparedness Act (PAHPA) was originally passed in 2006. That would leave 19% of staff affected by furloughs. But despite the law’s age, it is not yet fully operational.
Expert insights. Personalized for you.
40 
Let's personalize your content